Read Larry Connors' blog – Short Term Trading Strategies
Market Maker Friction Factor is shown in the chart below:
Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction
MNT $14.43 89.35% 13,541,947 54.25% 10,548,418 42.26% 2,993,529 2,075
MRX $1.77 14.47% 666,748 52.28% 512,563 40.19% 154,185 871
RCI $0.75 2.76% 431,903 45.78% 409,355 43.39% 22,548 301
ENSG $0.71 4.87% 73,177 50.12% 71,238 48.79% 1,939 27
RMBS $0.69 6.69% 4,158,708 51.67% 3,755,199 46.66% 403,509 5,848
EGY $0.56 8.86% 856,126 43.22% 846,914 42.75% 9,212 165
Click here to view chart: http://www.buyins.com/ff/fftopg12-1-08.jpg
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows MNT with a dollar gain Monday of +$14.43 and a Friction Factor of 2,075 shares. That means that it only took 2,075 more shares of buying than selling to move MNT higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
Mentor Corporation (NYSE: MNT | Quote | Chart | News | PowerRating) engages in the development, manufacture, licensing, and marketing of various products for the aesthetic and general surgery markets. Its products consist of surgically implantable breast implants, including saline-filled implants and silicone gel-filled implants for plastic and reconstructive surgery; capital equipment and consumables used for soft tissue aspiration or body contouring; breast reconstruction products, such as breast expanders; extremity tissue expanders; and facial rejuvenation products, including dermal filler products and cosmeceutical products for skin restoration. Its body contouring products comprise liposuction products and disposable supplies. The company also offers software, consulting, and business management tools for plastic surgeons. Mentor Corporation distributes its products through direct sale force in the United States, as well as through direct international sales offices and independent distributors primarily in Canada, Europe, Central and South America, and the Pacific Rim. The company was founded in 1969 and is headquartered in Santa Barbara, California.
Medicis Pharmaceutical Corporation (NYSE: MRX), together with its subsidiaries, operates as a specialty pharmaceutical company in the United States and Canada. It develops and markets products for the treatment of dermatological, aesthetic, and podiatric conditions. The companys products address various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis, and cosmesis. Its products include PLEXION for topical control of acne vulgaris, acne rosacea, and seborrheic dermatitis; SOLODYN, an antibiotic for the treatment of red, pus-filled pimples; TRIAZ, benzoyl peroxide pads for the topical treatment of acne vulgaris; and ZIANA, a gel used on the skin for treatment of acne in patients 12 and older. The company also offers LOPROX, a shampoo for the topical treatment of seborrheic dermatitis of the scalp in adults; PERLANE and RESTYLANE, which are cosmetic dermal fillers for the treatment of facial wrinkles and folds; and VANOS, a corticosteroid to relieve the inflammation and itching caused by certain skin conditions. In addition, Medicis Pharmaceutical provides non-dermatological products, including AMMONUL, a sodium phenylacetate and sodium benzoate injection for adjunctive treatment of acute hyperammonemia and associated encephalopathy in patients with urea cycle disorders; and BUPHENYL, an oral medication for the chronic adjunctive management of hyperammonemia in patients with urea cycle disorders. The company sells its products primarily to wholesale pharmaceutical distributors and retail pharmacy chains. It has a strategic alliance with AAIPharma, Inc. for the development, commercialization, and licensing of SOLODYN. Medicis Pharmaceutical also has strategic collaboration with Hyperion Therapeutics, Inc. and Revance Therapeutics, Inc. The company was founded in 1987 and is headquartered in Scottsdale, Arizona.
Rogers Communications, Inc. (NYSE: RCI | Quote | Chart | News | PowerRating) operates as a communications and media company in Canada. It operates in three segments: Wireless, Cable, and Media. The Wireless segment offers wireless voice, data, and messaging services. It operates a global system for mobile communications/general packet radio service network, which provides high-speed wireless data services, including mobile access to the Internet, wireless e-mail, digital picture and video transmission, mobile video, music downloading, video calling, and two-way short messaging services. The Cable segment provides cable television, cable telephony, and high-speed Internet access. It also owns and operates cable systems in Ontario, New Brunswick, and Newfoundland serving cable subscribers. This segment offers digital cable services; local telephone and long distance services; voice and data services; and IP access and application solutions, as well as provides digital video disc, and video game sales and rentals through a chain of video rental stores. The Media segment engages in radio and television broadcasting operations, and consumer and trade publishing operations, as well as offers televised home shopping services. As of December 31, 2007, it operated 52 radio stations; a spiritually-themed television station; a specialty sports television service that provides regional sports programming; a nationally televised shopping service; and The Biography Channel Canada. This segment also holds a 50% interest in Dome Productions, a mobile production and distribution joint venture. The company was founded in 1920 and is headquartered in Toronto, Canada.
The Ensign Group, Inc. (NASDAQ: ENSG), through its subsidiaries, provides nursing and rehabilitative care services in California, Arizona, Texas, Washington, Utah, and Idaho. It offers nursing and assisted living services; physical, occupational, and speech therapies; and other rehabilitative and healthcare services for long-term residents and short-stay rehabilitation patients. As of December 31, 2007, it owned or leased 61 facilities, including 26 company-owned facilities and 35 facilities through long-term lease arrangements. The Ensign Group was founded in 1999 and is based in Mission Viejo, California.
Rambus, Inc. (NASDAQ: RMBS | Quote | Chart | News | PowerRating) designs, develops, and licenses chip interface technologies and architectures that are used in digital electronics products. Its products include Fully Synchronous DRAM, which is designed to allow precise timing from a DRAM system; Dual Edge Clocking that is designed to allow data to be sent on the clock pulse; Variable Burst Length, which is designed to improve data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in DRAMs and flash memory; FlexPhase technology that synchronizes data output and compensates for circuit timing errors; and Channel Equalization, which is designed to improve signal integrity and system margins by reducing inter-symbol interference in high speed parallel and serial link channels. The companys chip interface products include XDR Memory Architecture, which enables the production of DRAM; XDR2 Memory Architecture, which includes DRAM micro-threading for graphics intensive applications, such as gaming and digital video; RDRAM Memory, which is used in play stations, Intel-based personal computers, televisions, and routers; and FlexIO processor bus, a high speed chip-to-chip interface. Its interface technologies are used in semiconductor and system products for computing, communications, and consumer electronics applications; and in personal computers, servers, printers, video projectors, video game consoles, digital TVs, set-top boxes, and mobile phones. In addition, the company offers industry-standard chip interface products, and digital logic controllers. Rambus, Inc. was founded in 1990 and is headquartered in Los Altos, California.
VAALCO Energy, Inc. (NYSE: EGY), an independent energy company, engages in the acquisition, exploration, development, and production of crude oil and natural gas. It holds interests in Etame Marin block, a 1,186 square mile offshore block containing 5 discoveries, including the Etame, Avouma, and South Tchibala fields that are on production, as well as the Ebouri field and the North Tchibala discovery in Gabon, west Africa. The company also has a 100% working interest in the 270,000 acre Mutamba Iroru block onshore Gabon. In addition, it holds interest in Block 5 offshore Angola, Africa; Block 9/28d offshore in the British North Sea; and Block 48/25c offshore in the British North Sea, as well as in four producing wells in Brazos County, Texas producing from the Buda/Georgetown formations and certain non-operated interests in Ship Shoal areas of the Gulf of Mexico. As of December 31, 2007, the company had total proved reserves of 6,214 million barrels of crude oil and 61 million cubic feet of natural gas. VAALCO Energy was founded in 1984 and is headquartered in Houston, Texas.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net
CONTACT: Thomas Ronk, CEO, Buyins.net Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
